Roivant Sciences (ROIV) Earnings Date
The next earnings date for Roivant Sciences (ROIV) is expected by Feb 10, 2027, per the data provider's calendar.
- Next earnings date
- Feb 10, 2027
- expected by · quarter ending Dec '26
- Consensus EPS
- $−0.29
- Dec '26 quarter · 2 analysts
- Consensus revenue
- $50.6M
- Dec '26 quarter · 3 analysts
- Latest stored quarter
- EPS −0.26
- revenue $1.4M · reported Aug 6, 2026
Does this company deliver against its own promises? Earnings are a check on the thesis, not a catalyst to chase.
1 of 1 scored quarter beat.
| Report | Est EPS | Act EPS | Surprise | Est rev | Act rev | Rev surp. | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 6, 20268-K, before open · 7:13 am ET | −0.29 | −0.26 | +9.8% | $2.0M | $1.4M | −27.8% | +1.5%release day |
| May 20, 20268-K, before open · 7:14 am ET | — | 0.34 | — | — | $2.5M | — | +14.9%release day |
| Feb 6, 20268-K, before open · 7:12 am ET | — | −0.38 | — | — | $2.0M | — | +22.1%release day |
| Nov 10, 20258-K, before open · 7:21 am ET | — | −0.17 | — | — | $1.6M | — | +2.7%release day |
| Aug 11, 20258-K, before open · 7:17 am ET | — | −0.33 | — | — | $2.2M | — | −2.8%release day |
| May 29, 20258-K, before open · 7:33 am ET | — | −0.28 | — | — | $7.6M | — | +6.4%release day |
| Feb 10, 20258-K, before open · 7:15 am ET | — | 0.23 | — | — | $9.0M | — | −0.9%release day |
| Nov 12, 20248-K, before open · 7:22 am ET | — | −0.31 | — | — | $4.5M | — | −1.4%release day |
Estimate-vs-actual scoring began Jul 2026 and is still accruing: 1 of the 8 quarters above carries a scored estimate. We never backfill an estimate we didn't observe.
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 2 | 1 | 3 | 4 |
| Avg estimate | −0.29 | −0.30 | −1.15 | −1.14 |
| Low estimate | −0.42 | −0.43 | −1.81 | −1.79 |
| High estimate | −0.12 | −0.12 | −0.46 | −0.46 |
| Year-ago EPS | −0.38 | 0.34 | −0.54 | −1.15E |
| Implied growth | — | −187.2% | — | — |
| Measure | Dec '26 | Mar '27 | FY26 | FY27 |
|---|---|---|---|---|
| No. of analysts | 3 | 6 | 7 | 9 |
| Avg estimate | $50.6M | $74.1M | $157.9M | $622.5M |
| Low estimate | $10.5M | $43.6M | $88.3M | $334.7M |
| High estimate | $74.4M | $99.6M | $204.8M | $865.3M |
| Year-ago revenue | $2.0M | $2.5M | $8.3M | $157.9ME |
| Implied growth | +2429.2% | +2842.3% | +1811.1% | +294.3% |
| Snapshot age | Dec '26, period ending Dec 30, 2026 | Mar '27, period ending Mar 30, 2027 | FY26, period ending Mar 31, 2027 | FY27, period ending Mar 31, 2028 |
|---|---|---|---|---|
| Current estimate | −0.29 | −0.30 | −1.15 | −1.14 |
| 7 days ago | −0.36 | — | −1.37 | −1.30 |
| 30 days ago | −0.37 | — | −1.38 | −1.31 |
| 60 days ago | −0.37 | — | −1.39 | −1.34 |
| 90 days ago | −0.31 | — | −1.25 | −1.05 |
Estimate history accrues from our nightly snapshots. The 7/30/60/90-day rows fill in as tracking continues. Each column follows one fiscal period back through our snapshots; a dash means we had not recorded that period at that age. A rising bar makes a beat streak more meaningful; a falling one manufactures beats.
Dec '26 quarter consensus moved $−0.31 → $−0.29 over 90 tracked days, the same quarter at both ends. Per-analyst up/down revision counts aren't in our data feed. We show the bar's actual movement instead of guessing.
Common questions
When does Roivant Sciences report earnings next?
Roivant Sciences' next earnings date is expected by Feb 10, 2027, per the data provider's calendar.
What were Roivant Sciences' latest quarterly earnings?
Roivant Sciences reported diluted EPS of −0.26 and revenue of $1.4M on Aug 6, 2026.
How did Roivant Sciences' stock move after its last earnings report?
Roivant Sciences moved +1.5% in the session after its Aug 6, 2026 report.

